Skip to main content
Clinical Trials/JPRN-UMIN000018986
JPRN-UMIN000018986
Completed
未知

Examination of usefulness and safety of heparinoid agent based external medicine (over counter drug) for facial dryness symptom. - Usefulness of heparinoid agent based external medicine for facial dryness symptom.

Osaka city university graduate school of medicine, department of dermatology0 sites50 target enrollmentSeptember 30, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Osaka city university graduate school of medicine, department of dermatology
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2015
End Date
December 24, 2015
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Osaka city university graduate school of medicine, department of dermatology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • The person 1\. Who takes in an oral pharmaceutical product or a supplement which may affect the skin condition habitually. 2\. Who had the anamnestic history of surgical operation on the testing area. 3\. Who is infected with hemorrhagic disease. 4\. Who has skin rash of atopic dermatitis on face. 5\. Who uses regularly an external medicine. 6\. Who had the anamnesis of heparinoid allergy. 7\. Who has allergy or sensitivity to drug and cosmetics. 8\. Who can not agree that using same cosmetics all over the study time. 9\. Who has skin disease on the testing area. 10\. Who has the factor on the testing area which may affect the result. 11\. Who has critical illness of glucose metabolism, lipid metabolism, liver function, renal function, cardiovascular system, respiratory tract, endocrine system, immune system and nervous system, or had the anamnestic history of psychiatric disorder. 12\. Who can not understand about examination contents. 13\. Who is pregnant or lactating. 14\. Who is impossible to come to the testing institution on an examination day. 15\. Who participates in other examinations. 16\. Who is recognized to be inappropriate as a subject by attending physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials